These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21928417)

  • 41. Fibroblast growth factor receptor 3-mediated reactivation of ERK signaling promotes head and neck squamous cancer cell insensitivity to MEK inhibition.
    Ban MJ; Byeon HK; Yang YJ; An S; Kim JW; Kim JH; Kim DH; Yang J; Kee H; Koh YW
    Cancer Sci; 2018 Dec; 109(12):3816-3825. PubMed ID: 30343534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [EphA2 mediated vascular endothelial growth factor expression via the p38 MAPK signaling pathway in squamous cell carcinoma of the head and neck].
    Liu Y; Tan HL; Li G; Yu CY; Su ZW; Ren SL; Zhu GC; Qiu YZ; Tian YQ; Zhang X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Mar; 48(3):229-33. PubMed ID: 23755789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of CD147 expression promotes chemosensitivity in HNSCC cells by deactivating MAPK/ERK signaling pathway.
    Ma C; Wang J; Fan L; Guo Y
    Exp Mol Pathol; 2017 Feb; 102(1):59-64. PubMed ID: 28062212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RN181 regulates the biological behaviors of oral squamous cell carcinoma cells via mediating ERK/MAPK signaling pathway.
    Li Y; Xiang ZY; Xiong J; Hou ZW; Zhu Z; Bao WW
    Acta Histochem; 2021 Jul; 123(5):151733. PubMed ID: 34052676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radioactive ¹²⁵I seed inhibits the cell growth, migration, and invasion of nasopharyngeal carcinoma by triggering DNA damage and inactivating VEGF-A/ERK signaling.
    Tian Y; Xie Q; Tian Y; Liu Y; Huang Z; Fan C; Hou B; Sun D; Yao K; Chen T
    PLoS One; 2013; 8(9):e74038. PubMed ID: 24040157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liprin-α1 contributes to oncogenic MAPK signaling by counteracting ERK activity.
    Pehkonen H; Filippou A; Väänänen J; Lindfors I; Vänttinen M; Ianevski P; Mäkelä A; Munne P; Klefström J; Toppila-Salmi S; Grénman R; Hagström J; Mäkitie AA; Karhemo PR; Monni O
    Mol Oncol; 2024 Mar; 18(3):662-676. PubMed ID: 38264964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of the extracellular signal-regulated kinases signaling pathway in squamous cell carcinoma of the skin.
    Zhang X; Makino T; Muchemwa FC; Lin T; Wakasugi S; Egawa K; Ihn H
    Biosci Trends; 2007 Dec; 1(3):156-60. PubMed ID: 20103886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Requirement of Runx3 in pulmonary vasculogenesis.
    Lee JM; Kwon HJ; Lai WF; Jung HS
    Cell Tissue Res; 2014 May; 356(2):445-9. PubMed ID: 24532149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychotropic drug tenoten activates mitogen-activated MAP/ERK kinase regulatory cascade controlling the neuroprotective effects.
    Epstein OI; Vorobieva OV; Grinkevich LN; Kharchenko OA; Shtark MB
    Bull Exp Biol Med; 2007 Sep; 144(3):319-21. PubMed ID: 18457026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Upregulation of calcium-sensing receptor and mitogen-activated protein kinase signalling in the regulation of growth and differentiation in colon carcinoma.
    Bhagavathula N; Kelley EA; Reddy M; Nerusu KC; Leonard C; Fay K; Chakrabarty S; Varani J
    Br J Cancer; 2005 Dec; 93(12):1364-71. PubMed ID: 16278666
    [TBL] [Abstract][Full Text] [Related]  

  • 51. β₁Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy.
    Eke I; Deuse Y; Hehlgans S; Gurtner K; Krause M; Baumann M; Shevchenko A; Sandfort V; Cordes N
    J Clin Invest; 2012 Apr; 122(4):1529-40. PubMed ID: 22378044
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The mitogen-activated protein kinase network, wired to dynamically function at multiple scales.
    Gagliardi PA; Pertz O
    Curr Opin Cell Biol; 2024 Jun; 88():102368. PubMed ID: 38754355
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanism underlying the bio-effects of an electromagnetic field based on the Huang-Ferrell model.
    Geng DY; Hu G; Wang L; Jia N; Wang FX
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27420980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclooxygenase inhibitors inhibit antibody response through interference with MAPK/ERK pathways and BLIMP-1 inhibition.
    Purssell E
    Med Hypotheses; 2014 Sep; 83(3):372-7. PubMed ID: 25012778
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The MAPK/ERK channel capacity exceeds 6 bit/hour.
    Nałęcz-Jawecki P; Gagliardi PA; Kochańczyk M; Dessauges C; Pertz O; Lipniacki T
    PLoS Comput Biol; 2023 May; 19(5):e1011155. PubMed ID: 37216347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single-Cell Imaging of ERK Signaling Using Fluorescent Biosensors.
    Pargett M; Gillies TE; Teragawa CK; Sparta B; Albeck JG
    Methods Mol Biol; 2017; 1636():35-59. PubMed ID: 28730471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective inhibition of EGFR downstream signaling reverses the irradiation-enhanced migration of HNSCC cells.
    Schuettler D; Piontek G; Wirth M; Haller B; Reiter R; Brockhoff G; Pickhard A
    Am J Cancer Res; 2015; 5(9):2660-72. PubMed ID: 26609474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of proton versus photon irradiation on (lymph)angiogenic, inflammatory, proliferative and anti-tumor immune responses in head and neck squamous cell carcinoma.
    Lupu-Plesu M; Claren A; Martial S; N'Diaye PD; Lebrigand K; Pons N; Ambrosetti D; Peyrottes I; Feuillade J; Hérault J; Dufies M; Doyen J; Pagès G
    Oncogenesis; 2017 Jul; 6(7):e354. PubMed ID: 28671677
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro effects of 0 to 120 Grays of irradiation on bone viability and release of growth factors.
    Sawada K; Fujioka-Kobayashi M; Kobayashi E; Brömme JO; Schaller B; Miron RJ
    BMC Oral Health; 2016 Jul; 17(1):4. PubMed ID: 27431387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retraction: Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK/MAPK signaling pathway by down-regulating HOXA1.
    Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36354012
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.